0.29 USD
↘ 0.01 (2.29%)AT CLOSE (11:59 AM EDT)
IGC Pharma, Inc.
IGCAMEX • USD
0.29
↗ 0.00 (1.05%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.29
↗ 0.00 (1.05%)
Market: CLOSED
Open?$0.29
High?$0.30
Low?$0.28
Prev. Close?$0.29
Volume?453.6K
Avg. Volume?663.7K
VWAP?$0.29
Rel. Volume?0.68x
Bid / Ask
Bid?$0.28 × 300
Ask?$0.30 × 86.1K
Spread?$0.02
Midpoint?$0.29
Valuation & Ratios
Market Cap?29.0M
Shares Out?100.1M
Float?73.5M
Float %?74.4%
P/E Ratio?N/A
P/B Ratio?4.74
EPS?-$0.07
Dividend?0.00%
Ex-Dividend?N/A
Shares of IGC Pharma, Inc. (IGC) are trading at $0.29. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, IGC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Address
10224 FALLS ROAD
POTOMAC, MD 20854
Phone: 301-529-4996
POTOMAC, MD 20854
Phone: 301-529-4996
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?65
Short Sent.?79
Piotroski F-Score?1/9Weak
Altman Z-Score?-16.76Distress
Confidence?47%Low
Short InterestLow
Short % of Float?1.76%Low
Short Interest?1.3M
Days to Cover?2.8
Free Float73.5M
Avg Daily Volume470.7K
Settlement Date2026-05-15
Financial Health
Current Ratio?0.40Weak
Quick Ratio?0.18Weak
Cash Ratio?0.07Low
Debt/Equity?0.15Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?4.74FAIR▾
Peers100
S&P38
P/S?24.85HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.9CHEAP▾
S&P97
EV/Sales?25.46HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-108.1%WEAK▾
S&P3
ROA?-72.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-4839000
Enterprise Value?$29.7M
Fundamentals ratios updated end of day